speb/financial-data huggingface dataset:
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4914649000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -351479000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3317050000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 435757000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.68
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 726554000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 61548000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -79319000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6184224000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 194663000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3869720000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 95230000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 99433000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -28858000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Inventory: -239835000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -28181000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 41621000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Payable: 79327000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 6772000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -253124000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -438414000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -531891000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Common Stock: 6184224000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10621011000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 459898000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1359107000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Assets: 15143646000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Debt: 1359131000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1359131000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 98777000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Assets: 1846000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 185171000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4003593000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Current Provisions: 84333000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 4306000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Depreciation: 38968000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 38968000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 435757000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.68
CYRE3.SA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 296776000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 60465000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — EBIT: 614982000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — EBITDA: 653950000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — End Cash Position: 194663000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 25276000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -45904000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Finished Goods: 5785693000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -188891000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -246825000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 33583000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 107368000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Goodwill: 12183000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 26609000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 984148000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Gross Profit: 665926000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 37852000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Interest Expense: 203701000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 203701000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Interest Income: 6259000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6259000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -143533000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Inventory: 5785693000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19413039000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -376415000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 3342326000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 717527000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7432897000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7432897000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 717527000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -767662000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 3188170000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 210072000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 61342000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1306988000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Minority Interests: -63283000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Net Debt: 8597365000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income: 296776000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 296776000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 360059000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 296776000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 296776000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 411281000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 360059000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -14631000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Interest Income: -204842000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -357561000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -50135000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -50135000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -204842000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 55173000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Net PPE: 632669000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -64688000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 10594402000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 101095000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 959208000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 888000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 332418000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 17465000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 654108000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Normalized Income: 296916620.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -109572000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Operating Income: 231537000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Operating Revenue: 2025033000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 366346855.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 365628000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 291570000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 53278000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 14426000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 336406000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2412457000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 44206000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Payable: 1307755000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Properties: 401360000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3675057000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Payables: 1728865000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 220452000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 69446450.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 43304000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Pretax Income: 411281000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 97127000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -14631000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -400809000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -64688000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1359107000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 38968000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 5027000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 5027000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -767662000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 296776000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 43248000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 198891000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 306259000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Share Issued: 384035916.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10621011000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 10594402000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -17380.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Tax Provision: 51222000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.11
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 26177000.00
CYRE3.SA cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -54608000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Assets: 26714090000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 18053908000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Debt: 8792028000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 11927999000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Total Expenses: 1793496000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 14786091000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 11570444000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 10782498000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 7400000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 70285000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Total Unusual Items: -158000.00
CYRE3.SA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -158000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 1830438000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 17689061.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 268905000.00
CYRE3.SA balance_sheet (quarterly, 2026-03-31) — Working Capital: 11140053000.00
CYRX cash_flow (annual, 2021-12-31) — Common Stock Issuance: 269825000.00
CYRX cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 518736000.00
CYRX cash_flow (annual, 2021-12-31) — Issuance Of Debt: 40068000.00
CYRX cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 40068000.00
CYRX balance_sheet (annual, 2021-12-31) — Net Debt: 266156000.00
CYRX cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 248911000.00
CYRX balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 419000.00
CYRX income_statement (annual, 2021-12-31) — Other Special Charges: 251754000.00
CYRX cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 248911000.00
CYRX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 8804000.00
CYRX cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 26000.00
CYRX income_statement (annual, 2022-12-31) — +Operating Expense: 135777000.00
CYRX income_statement (annual, 2022-12-31) — +Total Revenue: 237277000.00
CYRX balance_sheet (annual, 2022-12-31) — Accounts Payable: 28046000.00
CYRX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 43858000.00
CYRX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -27335000.00
CYRX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1114896000.00
CYRX balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
CYRX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CYRX income_statement (annual, 2022-12-31) — Basic Average Shares: 48987295.00
CYRX income_statement (annual, 2022-12-31) — Basic EPS: -0.93
CYRX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 139101000.00
CYRX balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4473000.00
CYRX cash_flow (annual, 2022-12-31) — Capital Expenditure: -24197000.00
CYRX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 28785000.00
CYRX balance_sheet (annual, 2022-12-31) — Capital Stock: 18323000.00
CYRX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 36595000.00
CYRX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 523323000.00
CYRX balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1843000.00
CYRX balance_sheet (annual, 2022-12-31) — Cash Financial: 34752000.00
CYRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -39174000.00
CYRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -59681000.00
CYRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1851000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Account Payable: -6483000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -1569000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Inventory: -14204000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -3076000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -941000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Payable: -6483000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -8052000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1658000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Receivables: -4137000.00
CYRX cash_flow (annual, 2022-12-31) — Change In Working Capital: -32068000.00
CYRX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -4137000.00
CYRX cash_flow (annual, 2022-12-31) — Changes In Cash: -100706000.00
CYRX balance_sheet (annual, 2022-12-31) — Common Stock: 48000.00
CYRX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 537563000.00
CYRX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CYRX cash_flow (annual, 2022-12-31) — Common Stock Payments: -37960000.00
CYRX balance_sheet (annual, 2022-12-31) — Construction In Progress: 15947000.00
CYRX income_statement (annual, 2022-12-31) — Cost Of Revenue: 133404000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6007000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Assets: 604176000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3848000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Debt: 60000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3908000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 439000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 439000.00
CYRX balance_sheet (annual, 2022-12-31) — Current Liabilities: 40851000.00
CYRX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 22765000.00
CYRX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 22765000.00
CYRX income_statement (annual, 2022-12-31) — Diluted Average Shares: 48987295.00
CYRX income_statement (annual, 2022-12-31) — Diluted EPS: -0.93
CYRX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -45333000.00
CYRX income_statement (annual, 2022-12-31) — EBIT: -28952000.00
CYRX income_statement (annual, 2022-12-31) — EBITDA: -6187000.00
CYRX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1800000.00
CYRX cash_flow (annual, 2022-12-31) — End Cash Position: 36595000.00
CYRX cash_flow (annual, 2022-12-31) — Financing Cash Flow: -39174000.00
CYRX cash_flow (annual, 2022-12-31) — Free Cash Flow: -26048000.00
CYRX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 102000.00
CYRX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 800000.00
CYRX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 8474000.00
CYRX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -34549000.00
CYRX balance_sheet (annual, 2022-12-31) — Goodwill: 151117000.00
CYRX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 342126000.00
CYRX balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 45158000.00
CYRX balance_sheet (annual, 2022-12-31) — Gross PPE: 117815000.00
CYRX income_statement (annual, 2022-12-31) — Gross Profit: 103873000.00
CYRX income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CYRX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1979000.00
CYRX income_statement (annual, 2022-12-31) — Interest Expense: 6142000.00
CYRX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6142000.00
CYRX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 3628000.00
CYRX balance_sheet (annual, 2022-12-31) — Inventory: 27678000.00
CYRX balance_sheet (annual, 2022-12-31) — Invested Capital: 944686000.00
CYRX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -59681000.00
CYRX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CYRX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CYRX balance_sheet (annual, 2022-12-31) — Land And Improvements: 813000.00
CYRX balance_sheet (annual, 2022-12-31) — Leases: 27083000.00
CYRX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 24937000.00
CYRX balance_sheet (annual, 2022-12-31) — Long Term Debt: 407063000.00
CYRX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 432000000.00
CYRX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CYRX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3262000.00
CYRX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 23076000.00
CYRX cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -6554000.00
CYRX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -37960000.00
CYRX balance_sheet (annual, 2022-12-31) — Net Debt: 370528000.00
CYRX income_statement (annual, 2022-12-31) — Net Income: -37333000.00
CYRX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -45333000.00
CYRX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -37333000.00
CYRX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -37333000.00
CYRX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -37333000.00
CYRX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -37333000.00
CYRX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -37333000.00
CYRX cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2090000.00
CYRX income_statement (annual, 2022-12-31) — Net Interest Income: -6142000.00
CYRX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -31930000.00
CYRX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -3262000.00
CYRX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -3262000.00
CYRX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -6142000.00
CYRX cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 3000000.00
CYRX balance_sheet (annual, 2022-12-31) — Net PPE: 90480000.00
CYRX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -22107000.00
CYRX cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CYRX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 213712000.00
CYRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 947000.00
CYRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4929000.00
CYRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 947000.00
CYRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4929000.00
CYRX balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1017000.00
CYRX income_statement (annual, 2022-12-31) — Normalized EBITDA: -14661000.00
CYRX income_statement (annual, 2022-12-31) — Normalized Income: -44027460.00
CYRX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1851000.00
CYRX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 902000.00
CYRX income_statement (annual, 2022-12-31) — Operating Income: -31904000.00
CYRX income_statement (annual, 2022-12-31) — Operating Revenue: 237277000.00
CYRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48334280.00
CYRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 9317000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 60000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -34549000.00
CYRX income_statement (annual, 2022-12-31) — Other Income Expense: 2952000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 191009000.00
CYRX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 12395000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 5128000.00
CYRX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -5522000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Properties: 45570000.00
CYRX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 486728000.00
CYRX balance_sheet (annual, 2022-12-31) — Payables: 28046000.00
CYRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 34053000.00
CYRX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2451000.00
CYRX balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 200000.00
CYRX balance_sheet (annual, 2022-12-31) — Preferred Stock: 18275000.00
CYRX income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 8000000.00
CYRX balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 18275000.00
CYRX cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
CYRX income_statement (annual, 2022-12-31) — Pretax Income: -35094000.00
CYRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2048000.00
CYRX cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 234000.00
CYRX cash_flow (annual, 2022-12-31) — Purchase Of Business: -6554000.00
CYRX cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2090000.00
CYRX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -163788000.00
CYRX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -22107000.00
CYRX balance_sheet (annual, 2022-12-31) — Receivables: 43858000.00
CYRX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 133404000.00
CYRX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 22765000.00
CYRX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3262000.00
CYRX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -37960000.00
CYRX income_statement (annual, 2022-12-31) — Research And Development: 15722000.00
CYRX balance_sheet (annual, 2022-12-31) — Retained Earnings: -542832000.00
CYRX cash_flow (annual, 2022-12-31) — Sale Of Investment: 131858000.00
CYRX income_statement (annual, 2022-12-31) — Selling General And Administration: 120055000.00
CYRX balance_sheet (annual, 2022-12-31) — Share Issued: 48334280.00
CYRX income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CYRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 20082000.00
CYRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 555838000.00
CYRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 195437000.00
CYRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1779540.00
CYRX income_statement (annual, 2022-12-31) — Tax Provision: 2239000.00
CYRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (annual, 2022-12-31) — Total Assets: 1038746000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Capitalization: 962901000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Debt: 435908000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 555838000.00
CYRX income_statement (annual, 2022-12-31) — Total Expenses: 269181000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 482908000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 434570000.00
CYRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 442057000.00
CYRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -31904000.00
CYRX income_statement (annual, 2022-12-31) — Total Unusual Items: 8474000.00
CYRX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 8474000.00
CYRX cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 11406000.00
CYRX balance_sheet (annual, 2022-12-31) — Working Capital: 563325000.00
CYRX income_statement (annual, 2023-12-31) — +Operating Expense: 126301000.00
CYRX income_statement (annual, 2023-12-31) — +Total Revenue: 168662000.00
CYRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 26995000.00
CYRX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 42074000.00
CYRX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -36588000.00
CYRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1131183000.00
CYRX balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2000000.00
CYRX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 49569000.00
CYRX income_statement (annual, 2023-12-31) — Basic Average Shares: 48737377.00
CYRX income_statement (annual, 2023-12-31) — Basic EPS: -2.21
CYRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 36595000.00
CYRX balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 6652000.00
CYRX cash_flow (annual, 2023-12-31) — Capital Expenditure: -44900000.00
CYRX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 35966000.00
CYRX balance_sheet (annual, 2023-12-31) — Capital Stock: 26324000.00
CYRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 46346000.00
CYRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 456755000.00
CYRX balance_sheet (annual, 2023-12-31) — Cash Equivalents: 5367000.00
CYRX balance_sheet (annual, 2023-12-31) — Cash Financial: 40979000.00
CYRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -23798000.00
CYRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 36045000.00
CYRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -757000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Account Payable: -2766000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 2884000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Inventory: 1508000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4595000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1137000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Payable: -2766000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 118000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -766000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Receivables: 3673000.00
CYRX cash_flow (annual, 2023-12-31) — Change In Working Capital: -1199000.00
CYRX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 3673000.00
CYRX cash_flow (annual, 2023-12-31) — Changes In Cash: 11490000.00
CYRX balance_sheet (annual, 2023-12-31) — Common Stock: 49000.00
CYRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 462748000.00
CYRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CYRX cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CYRX balance_sheet (annual, 2023-12-31) — Construction In Progress: 24224000.00
CYRX income_statement (annual, 2023-12-31) — Cost Of Revenue: 93329000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 8639000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Assets: 535112000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5657000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Debt: 149000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5806000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 1308000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 1308000.00
CYRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 45610000.00
CYRX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 27487000.00
CYRX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 27487000.00
CYRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 48737377.00
CYRX income_statement (annual, 2023-12-31) — Diluted EPS: -2.21
CYRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -107587000.00
CYRX income_statement (annual, 2023-12-31) — EBIT: -78634000.00
CYRX income_statement (annual, 2023-12-31) — EBITDA: -51147000.00
CYRX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1739000.00
CYRX cash_flow (annual, 2023-12-31) — End Cash Position: 46346000.00
CYRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -23798000.00
CYRX cash_flow (annual, 2023-12-31) — Free Cash Flow: -45657000.00
CYRX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 67000.00
CYRX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CYRX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 954000.00
CYRX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 10577000.00
CYRX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -26065000.00
CYRX balance_sheet (annual, 2023-12-31) — Goodwill: 108403000.00
CYRX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 302785000.00
CYRX balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 44074000.00
CYRX balance_sheet (annual, 2023-12-31) — Gross PPE: 154098000.00
CYRX income_statement (annual, 2023-12-31) — Gross Profit: 75333000.00
CYRX income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 49569000.00
CYRX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1462000.00
CYRX income_statement (annual, 2023-12-31) — Interest Expense: 5580000.00
CYRX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 5580000.00
CYRX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3399000.00
CYRX balance_sheet (annual, 2023-12-31) — Inventory: 26206000.00
CYRX balance_sheet (annual, 2023-12-31) — Invested Capital: 842785000.00
CYRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 36045000.00
CYRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CYRX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CYRX balance_sheet (annual, 2023-12-31) — Land And Improvements: 813000.00
CYRX balance_sheet (annual, 2023-12-31) — Leases: 33688000.00
CYRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 30309000.00
CYRX balance_sheet (annual, 2023-12-31) — Long Term Debt: 379888000.00
CYRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 410197000.00
CYRX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CYRX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -25276000.00
CYRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 31019000.00
CYRX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -7341000.00
CYRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CYRX balance_sheet (annual, 2023-12-31) — Net Debt: 333691000.00
CYRX income_statement (annual, 2023-12-31) — Net Income: -99587000.00
CYRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -107587000.00
CYRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -84559000.00
CYRX income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -15028000.00
CYRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -99587000.00
CYRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -84559000.00
CYRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -99587000.00
CYRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -99587000.00
CYRX cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -6115000.00
CYRX income_statement (annual, 2023-12-31) — Net Interest Income: -5580000.00
CYRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 87310000.00
CYRX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -25276000.00
CYRX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -25276000.00
CYRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -5580000.00
CYRX cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 976000.00
CYRX balance_sheet (annual, 2023-12-31) — Net PPE: 117510000.00
CYRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -38785000.00
CYRX cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
CYRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 186238000.00
CYRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 656000.00
CYRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2816000.00
CYRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 656000.00
CYRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2816000.00
CYRX balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 1680000.00
CYRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -17834000.00
CYRX income_statement (annual, 2023-12-31) — Normalized Income: -58241730.00
CYRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -757000.00
CYRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: -4658000.00
CYRX income_statement (annual, 2023-12-31) — Operating Income: -50968000.00
CYRX income_statement (annual, 2023-12-31) — Operating Revenue: 168662000.00
CYRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 48971026.00
CYRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 10077000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 149000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 92000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -26065000.00
CYRX income_statement (annual, 2023-12-31) — Other Income Expense: -27666000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 194382000.00
CYRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 6131000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 10098000.00
CYRX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 5647000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Properties: 55824000.00
CYRX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 410409000.00
CYRX income_statement (annual, 2023-12-31) — Other Special Charges: -5679000.00
CYRX balance_sheet (annual, 2023-12-31) — Payables: 26995000.00
CYRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 35634000.00
CYRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2770000.00
CYRX balance_sheet (annual, 2023-12-31) — Preferred Stock: 26275000.00
CYRX income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 8000000.00
CYRX balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 26275000.00
CYRX cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
CYRX income_statement (annual, 2023-12-31) — Pretax Income: -84214000.00
CYRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1478000.00
CYRX cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 822000.00
CYRX cash_flow (annual, 2023-12-31) — Purchase Of Business: -7341000.00
CYRX cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -6115000.00
CYRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -42677000.00
CYRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -38785000.00
CYRX balance_sheet (annual, 2023-12-31) — Receivables: 42074000.00
CYRX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 93329000.00
CYRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 27487000.00
CYRX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -25276000.00
CYRX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CYRX income_statement (annual, 2023-12-31) — Research And Development: 18040000.00
CYRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -642419000.00
CYRX cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CYRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 129987000.00
CYRX income_statement (annual, 2023-12-31) — Selling General And Administration: 108261000.00
CYRX balance_sheet (annual, 2023-12-31) — Share Issued: 48971026.00
CYRX income_statement (annual, 2023-12-31) — Special Income Charges: -43890000.00
CYRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 22808000.00
CYRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 489023000.00
CYRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 159963000.00
CYRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -6995730.00
CYRX income_statement (annual, 2023-12-31) — Tax Provision: 345000.00
CYRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (annual, 2023-12-31) — Total Assets: 957744000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 868911000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Debt: 416003000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 489023000.00
CYRX income_statement (annual, 2023-12-31) — Total Expenses: 219630000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 468721000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 422631000.00
CYRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 423111000.00
CYRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -100537000.00
CYRX income_statement (annual, 2023-12-31) — Total Unusual Items: -33313000.00
CYRX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -33313000.00
CYRX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -1308000.00
CYRX balance_sheet (annual, 2023-12-31) — Working Capital: 489502000.00
CYRX cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
CYRX balance_sheet (quarterly, 2024-09-30) — Current Debt: 14424000.00
CYRX income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
CYRX cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: -295000.00
CYRX balance_sheet (quarterly, 2024-09-30) — Net Debt: 154625000.00
CYRX balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 14424000.00
CYRX balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 3151000.00
CYRX income_statement (quarterly, 2024-09-30) — Other Special Charges: -17326000.00
CYRX income_statement (quarterly, 2024-09-30) — Special Income Charges: 17326000.00
CYRX income_statement (annual, 2024-12-31) — +Operating Expense: 127519000.00
CYRX income_statement (annual, 2024-12-31) — +Total Revenue: 156769000.00
CYRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 15895000.00
CYRX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 25304000.00
CYRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -37777000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -37777000.00
CYRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1145677000.00
CYRX balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -878000.00
CYRX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 63809000.00
CYRX cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
CYRX balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 36251000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 36251000.00
CYRX income_statement (annual, 2024-12-31) — Basic Average Shares: 49349624.00
CYRX income_statement (annual, 2024-12-31) — Basic EPS: -2.49
CYRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 46346000.00
CYRX balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 6809000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 6809000.00
CYRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -21267000.00
CYRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 43065000.00
CYRX balance_sheet (annual, 2024-12-31) — Capital Stock: 34325000.00
CYRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 34137000.00
CYRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 250597000.00
CYRX balance_sheet (annual, 2024-12-31) — Cash Equivalents: 134000.00
CYRX balance_sheet (annual, 2024-12-31) — Cash Financial: 34003000.00
CYRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -161531000.00
CYRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 176815000.00
CYRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -16323000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Account Payable: -76000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1852000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Inventory: 3252000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5340000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -556000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Payable: -76000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1776000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -3592000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Receivables: -4149000.00
CYRX cash_flow (annual, 2024-12-31) — Change In Working Capital: -8609000.00
CYRX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -4149000.00
CYRX cash_flow (annual, 2024-12-31) — Changes In Cash: -1039000.00
CYRX balance_sheet (annual, 2024-12-31) — Common Stock: 50000.00
CYRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 367623000.00
CYRX cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CYRX balance_sheet (annual, 2024-12-31) — Construction In Progress: 27145000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 27145000.00
CYRX income_statement (annual, 2024-12-31) — Cost Of Revenue: 87112000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8280000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 8280000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Assets: 341571000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3714000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Debt: 14441000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Current Debt: 14441000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 18155000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1061000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1061000.00
CYRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 64563000.00
CYRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 30757000.00
CYRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 30757000.00
CYRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 49349624.00
CYRX income_statement (annual, 2024-12-31) — Diluted EPS: -2.49
CYRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -122756000.00
CYRX income_statement (annual, 2024-12-31) — EBIT: -100372000.00
CYRX income_statement (annual, 2024-12-31) — EBITDA: -69615000.00
CYRX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -18000.00
CYRX cash_flow (annual, 2024-12-31) — End Cash Position: 45289000.00
CYRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -161531000.00
CYRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -37590000.00
CYRX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 4139000.00
CYRX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CYRX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 384000.00
CYRX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 9895000.00
CYRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -20929000.00
CYRX balance_sheet (annual, 2024-12-31) — Goodwill: 20569000.00
CYRX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 168496000.00
CYRX balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 26182000.00